Cargando…
Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
High-grade Bladder Cancer (BLCA) represents the most aggressive and treatment-resistant cancer that renders the patients with poor survival. However, only a few biomarkers have been identified for the detection and treatment of BLCA. Recent studies show that ganglioside GD2 can be used as cancer bio...
Autores principales: | Vantaku, Venkatrao, Donepudi, Sri Ramya, Ambati, Chandrashekar R., Jin, Feng, Putluri, Vasanta, Nguyen, Khoa, Rajapakshe, Kimal, Coarfa, Cristian, Battula, Venkata Lokesh, Lotan, Yair, Putluri, Nagireddy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707048/ https://www.ncbi.nlm.nih.gov/pubmed/29221154 http://dx.doi.org/10.18632/oncotarget.21038 |
Ejemplares similares
-
Correction: Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
por: Vantaku, Venkatrao, et al.
Publicado: (2019) -
Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors
por: Ballester, Leomar Y., et al.
Publicado: (2018) -
Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival
por: von Rundstedt, Friedrich-Carl, et al.
Publicado: (2016) -
EMT-induced metabolite signature identifies poor clinical outcome
por: Bhowmik, Salil Kumar, et al.
Publicado: (2015) -
Lipidomic Profiling Identifies a Novel Lipid Signature Associated with Ethnicity-Specific Disparity of Bladder Cancer
por: Kami Reddy, Karthik Reddy, et al.
Publicado: (2022)